Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim report 4, October – December 2023

Fourth quarter October 1 – December 31, 2023 Group · Operating income amounted to SEK 8,428K (SEK 8,121K) · Operating profit amounted to SEK 814K (SEK -6,559K) · Net profit after income taxes amounted to SEK 831K (SEK -6,875K) · Net profit per share after income taxes amounted to SEK 0.03 (SEK -0.44) (Amounts within parentheses refer to the corresponding figures for the same period the prior year) Full year January 1 – December 31, 2023 Group · Operating revenue amounted to SEK 26,999K (21,664K). · Operating profit amounted to SEK -15,375K (-28,230K). ·

Cambio Year End Report Q4 2023

We had a strong fourth quarter, characterized by solid profitable growth and important customer wins. Customer Group KGC (Kundgrupp Cosmic), which consists of eight Swedish regions and one private care giver, has signed an extension of its COSMIC contract for another 5 years with 3 additional option years. This is a testament to the strong relationship between KGC and Cambio that has been developed over the last years. In the fourth quarter, we received a major order worth 84 MSEK to provide additional functionality to KGC, which will be delivered during 2023 and 2024. The order

Year-end report January – December 2023

Oslo, Norway, February 29, 2024 - Genetic Analysis AS (the "Company", Ticker: GEAN) hereby publishes the year-end report for the period 1 January - December 31, 2023. The year-end report is available as an attached file to this release and on the Company's website. Below is a summary of the report.Ronny Hermansen, CEO of Genetic Analysis, comments:"2023 was a year when we increased our presence in the microbiome testing market and took a leap forward in our commercialization journey. We have further developed and enhanced our GA-map® platform, entered into new distribution agreements, and

Ratos AB – change in number of shares and votes

The fifth opportunity to exercise warrants according to the incentive program for the CEO and other key personnel in Ratos decided on by the 2019 Annual General Meeting was completed in February 2024. Through the exercise of 329,200 warrants, the number of Class B shares increased by 329,200 and the number of votes by 32,920. After the increase, the share capital amounts to SEK 1,029,563,917.20.  Before   After exercise of warrants and conversion, no.exercise ofwarrantsandconversion,no.Class A 84,637,060   Class A shares: 84,637,060

Sanolium contemplates issuance of new senior secured bonds, announces a conditional tender offer for its outstanding 2019/2024 bonds and gives a conditional call notice of early redemption

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS MAY BE RESTRICTED BY LAW Sanolium AB (publ) (the “Company” or “Sanolium”) has mandated DNB Markets, a part of DNB Bank ASA, Sweden Branch as Global Coordinator and Joint Bookrunner and Carnegie Investment Bank AB (

Flexion releases a trading update and estimates a quarterly revenue record in Q4 2023

LONDON, 29th of February 2024 – Flexion Mobile Plc (Nasdaq: FLEXM), the games marketing company releases a trading update for Q4 2023. During the quarter monthly revenue records were broken several times which resulted in an all-time high for the quarter with an estimated total revenue of GBP 24.3m. The growth was driven both by newly launched titles, existing titles in the top-end of our portfolio as well as Audiencly’s 7vsWild project. This is in line with the revenue guidance of GBP 22-29m for the quarter. Estimated quarter-on-quarter revenue growth for Q4 was 64% and estimated

Foresees a noticeable increase of customers, volume, and sales in 2024

STOCKHOLM - February 29, 2024 - Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, saw important pieces fall into place during the fourth quarter, the foremost being our attainment of accreditation as a medical laboratory. This paved the way for making Inify’s diagnostic service fully available to both private and public healthcare providers, resulting in a sales growth of 176% compared to the third quarter. “I dare to claim that our operations are unique – in Sweden, and internationally. Our ambition is to stay at the forefront in terms of

JonDeTech Sensors - Building for exciting 2024 - Mangold Insight Analysis

Mangold is updating its view on JonDeTech Sensors (JonDeTech). In the fourth quarter, the company delivered the first JIRS40 to Yoyon with additional products delivered in January. The delivery related to smart locks and dialog is conducted around extended uses and recurring orders. In addition, the company received a design win and orders from GMT for SEK 0.9 million regarding presence detection for smart refrigerators. The company is well on the way to commercializing JIRE10 and JIRS30 which will diversify revenue streams and, in our judgment, lead to progressively increased revenue.The

Unaudited Net Asset Value Update (January 2024)

[A green triangle with black letters Description automatically generated]     Thursday, 29 February 2024 KR1 plc (“KR1” or the “Company”) Unaudited Net Asset Value Update KR1 plc (KR1:ASE), a leading digital asset investment company, is pleased to announce its unaudited net asset value ("NAV") as at 31 January 2024.   Net Asset Value £218,119,989Shares in issue 177,369,520NAV per share 122.97pGBP/USD rate (as at 31 January 2024) 1.2679   Income from

Change in the number of shares and votes

According to previously published information, Fastighets AB Balder (publ) has carried out a directed issue of 18,000,000 Series B shares. The issue has resulted in a change in the number of shares and votes. The total number of shares as of February 29, 2024 amounts to 1,172,000,000 shares, of which 67,376,592 Series A shares and 1,104,623,408 Series B shares. The total number of votes amounts to 177,838,932.8, of which the Series A shares correspond to 67,376,592 votes and the Series B shares correspond to 110,462,340.8 votes. For further information, please contact:Erik Selin,

Relais Group Plc will publish its Financial Statements Review 2023 on 7 March 2024 at 9:00 a.m. EET, webcast at 10:00 a.m.

Relais Group PlcPress Release 29 February 2024 at 9:00 a.m. EET Relais Group Plc will publish its Financial Statements Review 2023 on Thursday, 7 March 2024 at 9:00 a.m. EET and it will be available after publishing on the company's website at https://relais.fi/en/investors/. Relais Group will arrange a webcast for analysts, investors and media on 7 March 2024, at 10:00 a.m. EET. The webcast will be held in English. Relais Group’s CEO Arni Ekholm and CFO Thomas Ekström will host the event. The webcast can be followed at https://relais.videosync.fi/q4-2023. Presentation material

Accelerating Momentum: Irisity’s Path to Sustained Profitability

[A black background with a black square Description automatically generated with medium confidence]                                                                                           Press release 2024-02-29   The CEO comments on the fourth quarter:   Through a transformative Q4, Irisity has demonstrated growth and advancement. Key developments include expanded sales hires in key regions such as the UK, US and Middle East, with a R&D focusing on market demand and personalized AI for customer specific use cases.Our net revenue increased by 121% YoY to MSEK 27.6, while

Swecon and Metso sign a distribution agreement in the Baltic region

Metso Corporation’s press release on February 29, 2023, at 09:00 a.m. EETMetso has signed a distribution agreement with a new distribution partner, Swecon, in the Baltic region. Swecon will cover the markets in Estonia, Latvia, and Lithuania. This partnership marks a step forward for both companies, and enables enhanced accessibility and service for our valued customers in the Baltic region. “We are delighted to have Swecon as our exclusive distributor for equipment, parts and services. Swecon is a leading supplier of state-of-the-art construction machinery, present in various service

SCA publishes 2023 annual report

SCA publishes its annual report for the year 2023 today.   Through significant strategic investments, such as the capacity increase at the paper mill in Obbola, pulp production in Ortviken and the modernization of the Bollsta sawmill, SCA strengthens its production capacity and its value chain. These measures, along with the startup of a jointly owned biorefinery in Gothenburg, position the company well to meet an increasing demand for climate-smart products. The company's high self-sufficiency in forest raw materials, energy, and logistics creates favorable conditions for maintaining

Fortum Battery Recycling and Hydrovolt join forces to drive the Nordic battery industry forward

FORTUM CORPORATION PRESS RELEASE 29.2.2024 Fortum Battery Recycling and Hydrovolt, a Nordic battery recycler, have signed an agreement on the delivery of black mass to Fortum’s battery material recycling plant in Finland. The scope of the collaboration includes a cross-Nordic process: first, Hydrovolt mechanically recycles EV batteries at its first industrial plant in Fredrikstad, Norway. After the batteries are crushed and turned into black mass, the material is then shipped to Fortum’s hydrometallurgical plant in Harjavalta for further processing. At Harjavalta, the cutting-edge

Synergi’s data reveals EV drivers could be missing out on 236€ a year off charging costs

A new report from smart energy company Synergi has revealed novel data about how EV drivers use smart charging services in Finland. The data was gathered from thousands of smart charging sessions on the Synergi smart electricity app during 2023.Key Findings · The most popular EV brands for smart charging are Tesla, BMW, Volkswagen, Audi, SKODA, Mercedes Benz, Kia, Hyundai, Volvo, Renault, Jaguar and Toyota.  · From all EV smart charging users, 80% percent have a spot price contract, 16% have a fixed price contract, and 4% a demand response contract.  · The top savings for an EV

UIE's Annual Report 2023

On 29 February 2024, UIE Plc. ("UIE") announced its Annual Report 2023. In 2023, UIE’s net result was USD 120.6 million compared to a net loss of USD 22.1 million in 2022, reflecting another record-high result from UP as well as a significant fair value increase of the Schörling investment. UIE's Business Reporting Highlights 2023: UP: · UIE's share of UP's result increased by 13% to USD 74.3 million in 2023 · UP reported a record-high net profit of MYR 711.0 million due to higher production volumes of CPO and PK as well as higher selling prices of CPO · In local

Interim full-year report 2023

Company Announcement no. 7-24Copenhagen, February 29, 2024 This announcement is a summary and should be read in conjunction with Shape Robotics’ interim full-year report for 2023, published on February 29, 2024. The interim report will be available on the company’s website . The full-year report is not audited. The audited annual report for 2023 is expected to be released on April 3, 2024. Financial highlights · The Company has realized a YTD revenue of MDKK 171.213 (87.385) · Contribution Margin YTD amounts to MDKK 48.133 (26.484)

ABAX SHOW SOLID REVENUE AND EBITDA GROWTH IN THE FOURTH QUARTER (Q4)

29.02.2024, Larvik, Norway | ABAX Group announces its Q4 2023 results. The Q4 report is available on the company website at: https://www.abax.comHighlights Q4: · Operational Revenue of 204,9 (190,61) MNOK, 7 % growth year-over-year   · Adjusted EBITDA of 74,9 (71,5) MNOK, 5 % growth year-over-year. · Annual Recurring Revenue (ARR) of 816,6 MNOK, up 8 % year-over-year · Acquisition of Movolytics to strengthen our position in the UK market  · Launch of FAIR in Sweden, a new independent car insurance broker brand developed todeliver data-driven value to connected fleet

Read original

The Nomination Committee’s proposal regarding Wihlborgs Fastigheter AB (publ)

The members of the Nomination Committee were elected by the 2023 Annual General Meeting and consists of Göran Hellström (Backahill AB), Elisabet Jamal Bergström (SEB Investment Management AB), Johannes Wingborg (Länsförsäkringar Fondförvaltning) and Caroline Sjösten (minor shareholders). Göran Hellström has been the chairman of the nomination committee. By the end of 2023, the Nomination Committee represented 26.8 percent of the votes in Wihlborgs. In its submission to the AGM of Wihlborgs Fastigheter AB (publ) on 24 April 2024, the nomination committee proposes that the board of

Archer Limited: 36% EBITDA-growth in 2023 and positive net income in the quarter

Hamilton, Bermuda (February 29, 2024) Archer today releases the fourth quarter and preliminary full-year 2023 financial report and reports positive net income of $8.5 million for the quarter, in line with the trading update released on January 26, 2024. Some highlights from the financial report: · Revenue of $305 million and adjusted EBITDA of $33.4 million in Q4 2023, a year-on-year increase of 15% and 14%, respectively. · EBITDA grew by 36% in 2023, exceeding upper range of full-year guidance. · Reduced leverage ratio to 2.9 at year-end 2023. · Positive net income for

Apalutamide Study Again Demonstrates the Advantages of Nanoforming Over Traditional Cancer Treatment Formulations

Press Release Nanoform Finland Plc  February 29, 2024  08:11 a.m. Finnish time / 07:11 a.m. Swedish time  Apalutamide Study Again Demonstrates the Advantages of Nanoforming Over Traditional Cancer Treatment Formulations Helsinki, Finland – February 29, 2024 – Nanoform Finland Plc (“Nanoform”), the medicine performance-enhancing company, today announced it had received positive results from its own pre-clinical, in-vivo study of a nanocrystalline-enabled apalutamide oral formulation, which shows potential to enable a much smaller tablet than Erleada[® [1]], a nonsteroidal

Strong momentum in Project Nanoenzalutamide

Company Announcement Nanoform Finland Plc February 29, 2024 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Strong momentum in Project Nanoenzalutamide Project Nanoenzalutamide sees strong momentum. The clinical results in the pilot study were very promising. Now we are preparing for the manufacture of nanoformed material for the registration batches and the EU/US pivotal studies that are planned to start during 2024. In parallel, Nanoform and the members of the ONConcept[® ]Consortium have initiated discussions with many potential partners around this exciting project. The

Update on rights issue process, extraordinary general meeting, and financial calendar

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT IS NOT A PROSPECTUS AS DEFINED BY REGULATION (EU) NO. 2017/1129 OF JUNE 14, 2017 AND DOES NOT CONSTITUTE A PUBLIC OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Aquaporin A/S, Nymøllevej 78, DK-2800 Kongens Lyngby, aquaporin.com, Company registration no.: DK28315694 Company announcementNo. 03/2024 - Inside

There are no items matching the current filter
There are no more items matching the current filter
Back to top